BioCatalystWatch
CCCCWorkspace / CCCC / OverviewCompany library
C4 Therapeutics, Inc. logo

C4 Therapeutics, Inc.

C4 Therapeutics, Inc. (CCCC)

Website

Price
Market cap
Next catalystExpected Q1 2027Cemsidomide + dexamethasone — MOMENTUM · Enrollment completionCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

Cemsidomide

IKZF1 × IKZF3

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

CemsidomideCemsidomide + dexamethasone — MOMENTUM

IKZF1 × IKZF3

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Cemsidomide

IKZF1 × IKZF3

PreINDP2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Cemsidomide

IKZF1 × IKZF3

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

CemsidomideCemsidomide + dexamethasone — MOMENTUM

IKZF1 × IKZF3

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Cemsidomide

IKZF1 × IKZF3

PreINDP2P3FilingApproved
Upcoming / outlook

Other pipelines

Cemsidomide

IKZF1 × IKZF3

PreINDP1P2FilingApproved
Upcoming / outlook

  • Timing and evidence

Partner / License out

EGFR L858R × EGFR L861Q

PreINDP1P2P3FilingApproved

IRAK4

History / paused

Cemsidomide

IKZF1 × IKZF3

PreINDP1P2P3FilingApproved
Cemsidomide

IKZF1 × IKZF3

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

CCCC PR & News

PR & News

CCCC SEC archive